People
In the cannabis sector of drug development, there is a movement happening. And Rob Davidson, chief executive officer of CURE Pharmaceuticals is making sure his company is ready for the next steps.
This morning Starboard Value LP issued an investor presentation opposing the proposed deal. The group will share the materials with other shareholders in hopes to sway support for its opposition.
The French company has an age limit for its top official and the company is working on a succession plan in anticipation of that change.
The Nomination Committee has consisted of Axel Calissendorff, Chairman of the nomination committee, Lars Backsell, Johan Lannebo and Ossian Ekdahl.
Vejthani Hospital, one of the leading hospitals specializing in bone and joint treatment in Thailand, called on patients suffering from complications caused by diseases such as diabetes to regularly care for their health and practice self-monitoring, including taking care of their wounds and checking their nervous system, to prevent the occurrence of Charcot foot.
March is National Women’s Month with March 8 specifically designated as International Women’s Day. Although this is not remotely a comprehensive list, BioSpace recognizes these 10 women (in no particular order) as being especially influential in the biopharma industry.
The life sciences industry is incredibly important to the financial ecosystem of the Golden State. Last year the industry generated total annual revenue of $177.1 billion in the state.
March is Women’s History Month, with March 8 designated as International Women’s Day. Let’s take a look at 10 pioneers, some still alive, and some who are no longer with us, who are pioneers in the field of biotechnology.
The latest financing round will boost the study of KarXT, Karuna’s lead product candidate, which is currently in Phase II development as a potential treatment for acute psychosis in patients with schizophrenia.
Within the non-medical community, there is a tendency to just refer to dementia and Alzheimer’s interchangeably, but the Alzheimer’s Disease-Related Dementias Summit 2019 emphasized that physicians need to make the distinction for best patient care.
PRESS RELEASES